Clinical Evidence That Zestra® Works
Zestra® has been established, in two randomized, placebo-controlled, double-blind clinical trials, to significantly improve woman’s desire, arousal and sexual satisfaction. In these clinical trials, 70% of women reported improved sexual satisfaction. This was achieved over multiple uses.
Results from the first clinical trial – a pilot study of women with and without sexual complaints – were published in 2003 by the Journal of Sex and Marital Therapy.
Clinical Efficacy: Primary Endpoint Female Sexual Function Index (FSFI)
In 2007, a large clinical trial on 256 women, ages 21–65, with mixed desire/ interest/arousal/orgasm disorders, was conducted at 17 leading sexual health centres across the US. Results of this large-scale study were published in 2010 in the Journal of Sex and Marital Therapy. If you want more details regarding trial design, inclusion criteria, demographics, evaluation method and results, you can download the summary or the full publication.
Clinical Efficacy-Secondary EndpointWomen’s Inventory of Treatment Satisfaction (WITS)
Results from the first clinical trial – a small pilot study of women with and without sexual complaints – were published in 2003 by the Journal of Sex & Marital Therapy. In 2007, a large clinical trial was conducted at 13 leading sexual health centers across the US. Results of this large-scale study were published in 2010.
These studies included women at different stages of life with a wide array of medical conditions, as well as women who were taking medications thought to be associated with lowering libido.
In the clinical studies, the only observed adverse event was genital burning (14%) in Zestra®-treated subjects, which subsided without treatment in 5 to 30 minutes.
Zestra® has been available in the US for 10 years and has shown an excellent safety profile.
The genital burning sometimes reported is often associated with improper application of the product. It is important for your patient to follow the instructions or watch the How to apply Zestra® video.
Furthermore, the active ingredients in Zestra® are very well-known, and side effects reported are rare, particularly in topical application.
This excellent safety profile establishes Zestra® as a first-line treatment of choice for your patients suffering from female sexual interest and arousal disorder.